Allspring Global Investments
PACB icon

Allspring Global Investments’s Pacific Biosciences PACB Stock Holding History

Allspring Global Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,962
Closed -$175K – 2593
2023
Q3 		$175K Buy
20,962
+7,184
+52% +$82.1K ﹤0.01% 1795
2023
Q2 		$183K Buy
13,778
+3,107
+29% +$37.8K ﹤0.01% 1838
2023
Q1 		$124K Buy
10,671
+2,846
+36% +$28.3K ﹤0.01% 1968
2022
Q4 		$64K Sell
7,825
-172
-2% -$1.48K ﹤0.01% 2245
2022
Q3 		$46K Hold
7,997
– – ﹤0.01% 2384
2022
Q2 		$35K Sell
7,997
-66,523
-89% -$404K ﹤0.01% 2359
2022
Q1 		$678K Buy
74,520
+25
+0% +$288 ﹤0.01% 2095
2021
Q4 		$1.52M Buy
+74,495
New +$1.8M ﹤0.01% 1687

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Allspring Global Investments's PACB Position: Q4 2023 in Review

Allspring Global Investments sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 20,962 shares — an estimated $175K sold.

Allspring Global Investments first reported a position in PACB in Q4 2021 and held it in 8 quarters. The position peaked at $1.52M in Q4 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Allspring Global Investments reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 20,962 Pacific Biosciences shares in Q4 2023, an estimated $175K.
  • Allspring Global Investments first reported a position in Pacific Biosciences in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Pacific Biosciences position peaked at $1.52M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.